Success Metrics

Active Trials
7(88%)

Phase Distribution

Ph phase_3
1
13%
Ph phase_2
3
38%
Ph not_applicable
4
50%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

8

all time

Status Distribution
Active(7)
Other(1)

Detailed Status

Recruiting7
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
7
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 23 (37.5%)
Phase 31 (12.5%)
N/A4 (50.0%)

Trials by Status

unknown113%
recruiting788%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
RADIATION
Total Trials
8